Knowing healthy postprandial glucose values is a worthwhile target to get healthier. A Cleveland Clinic expert shares the sweet spot and tips to keep your blood sugar steady.

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

At ATTD 2026, Dexcom (Nasdaq:DXCM) outlined a range of ways in which its continuous glucose monitors (CGMs) benefit people with diabetes.

U.S. Insulin Delivery Devices Market was valued at USD 7.35 billion in 2025 and is expected to reach USD 15.74 billion by 2035 due to the exceptionally high diabetes prevalence.Austin, March 20, 2026 ...

The healthcare giant is roughly 22% down from its 52-week high of $139.06 as of writing. However, for investors focused on ...

MiniMed is out to prove it deserves the name, with a new FDA clearance for its smallest insulin pump yet.  | At about half the size of the 780G pump, the shape of the 300-unit MiniMed Flex is ...

Consumer sleep technology (CST), popularly known as sleep trackers, is designed to help individuals become aware of their sleep patterns and to promote better, healthier sleep. But these apps and ...

Should A1c remain the gold standard for routine monitoring of glucose control in people with diabetes, or is it time to shift ...

Diabetes Care Devices Market Insights, Competitive Landscape, and Market Forecast - 2034” report provides the current ...

But as these products proliferate, manufacturers face a new set of questions. How do expectations around comfort, usability, ...

Diabetes technology innovators gathered last week for the Advanced Technologies and Treatments for Diabetes Conference (ATTD 2026).

Abbott Laboratories (ABT) stock has slipped roughly 13% year-to-date, a pullback that has caught the attention of income-focused investors. The healthcare giant has a record of more than five decades ...